OSE Immunotherapeutics OSE
PAR: OSE | ISIN: FR0012127173 15/07/2025
5,100 EUR (-0,20%)
(-0,20%)
15/07/2025
Profiel OSE Immunotherapeutics
CEO: Alexis Peyroles
CEO: Alexis Peyroles